Fennec Pharmaceuticals: H.C. Wainwright raises target price to $17 from $16
FENC•H.C. Wainwright raised its target price for Fennec Pharmaceuticals to $17 from $16.
Related News

Meridian Holdings subsidiary Expanse Studios signs distribution deal with Playtech
MRDN•

AI stocks rally as Nvidia outlook calms demand fears
NVDA•

ZKH Group Q3 net profit swings to RMB 42.38 million
ZKH•

TSX futures slip as lower commodity prices weigh; Fed minutes in focus
SPY•

Wells Fargo raises Procter & Gamble target price to $188 from $180
PG•